Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Is strongyloidiasis endemic in Spain?.

PLoS neglected tropical diseases

Martinez-Perez A, Lopez-Velez R.
PMID: 25654324
PLoS Negl Trop Dis. 2015 Feb 05;9(2):e0003482. doi: 10.1371/journal.pntd.0003482. eCollection 2015 Feb.

No abstract available.

Cite
Martinez-Perez A, Lopez-Velez R. Is strongyloidiasis endemic in Spain?. PLoS Negl Trop Dis. 2015;9(2):e0003482doi: 10.1371/journal.pntd.0003482.
Martinez-Perez, A., & Lopez-Velez, R. (2015). Is strongyloidiasis endemic in Spain?. PLoS neglected tropical diseases, 9(2), e0003482. https://doi.org/10.1371/journal.pntd.0003482
Martinez-Perez, Angela, and Lopez-Velez, Rogelio. "Is strongyloidiasis endemic in Spain?." PLoS neglected tropical diseases vol. 9,2 (2015): e0003482. doi: https://doi.org/10.1371/journal.pntd.0003482
Martinez-Perez A, Lopez-Velez R. Is strongyloidiasis endemic in Spain?. PLoS Negl Trop Dis. 2015 Feb 05;9(2):e0003482. doi: 10.1371/journal.pntd.0003482. eCollection 2015 Feb. PMID: 25654324; PMCID: PMC4318575.
Copy Download .nbib Format: NLM
Vittaforma Corneae keratoconjunctivitis: An emerging pathology among travelers returning from Southeast Asia.

Archivos de la Sociedad Espanola de Oftalmologia

Arnalich-Montiel F, de-Arriba-Palomero P, de Dompablo E, Carrillo-Gijon R, Lopez-Velez R, Lorenzo-Morales J.
PMID: 32660763
Arch Soc Esp Oftalmol (Engl Ed). 2020 Nov;95(11):569-572. doi: 10.1016/j.oftal.2020.04.017. Epub 2020 Jul 10.

Microsporidium keratoconjunctivitis is an very rare disease. It is related to outbreaks in Asia due to exposure to contaminated water or soil. Microsporidium keratoconjunctivitis is a a self-limited disease, but it could have long term courses. We present the...

Cite
Arnalich-Montiel F, de-Arriba-Palomero P, de Dompablo E, et al. Queratoconjuntivitis por Vittaforma corneae: una enfermedad emergente entre los viajeros que regresan del sudeste asiático. Vittaforma Corneae keratoconjunctivitis: An emerging pathology among travelers returning from Southeast Asia. Arch Soc Esp Oftalmol (Engl Ed). 2020;95(11):569-572doi: 10.1016/j.oftal.2020.04.017.
Arnalich-Montiel, F., de-Arriba-Palomero, P., de Dompablo, E., Carrillo-Gijon, R., Lopez-Velez, R., & Lorenzo-Morales, J. (2020). Queratoconjuntivitis por Vittaforma corneae: una enfermedad emergente entre los viajeros que regresan del sudeste asiático. Vittaforma Corneae keratoconjunctivitis: An emerging pathology among travelers returning from Southeast Asia. Archivos de la Sociedad Espanola de Oftalmologia, 95(11), 569-572. https://doi.org/10.1016/j.oftal.2020.04.017
Arnalich-Montiel, F, et al. "Queratoconjuntivitis por Vittaforma corneae: una enfermedad emergente entre los viajeros que regresan del sudeste asiático." Vittaforma Corneae keratoconjunctivitis: An emerging pathology among travelers returning from Southeast Asia. Archivos de la Sociedad Espanola de Oftalmologia vol. 95,11 (2020): 569-572. doi: https://doi.org/10.1016/j.oftal.2020.04.017
Arnalich-Montiel F, de-Arriba-Palomero P, de Dompablo E, Carrillo-Gijon R, Lopez-Velez R, Lorenzo-Morales J. Queratoconjuntivitis por Vittaforma corneae: una enfermedad emergente entre los viajeros que regresan del sudeste asiático. Vittaforma Corneae keratoconjunctivitis: An emerging pathology among travelers returning from Southeast Asia. Arch Soc Esp Oftalmol (Engl Ed). 2020 Nov;95(11):569-572. doi: 10.1016/j.oftal.2020.04.017. Epub 2020 Jul 10. Spanish. PMID: 32660763.
Copy Download .nbib Format: NLM
Corrigendum to "The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII" [Mol Genet Metab 2020 Mar;129(3):219-227].

Molecular genetics and metabolism

Wang RY, da Silva Franco JF, López-Valdez J, Martins E, Sutton VR, Whitley CB, Zhang L, Cimms T, Marsden D, Jurecka A, Harmatz P.
PMID: 32843286
Mol Genet Metab. 2020 Sep - Oct;131(1):285. doi: 10.1016/j.ymgme.2020.08.001. Epub 2020 Aug 23.

No abstract available.

Cite
Wang RY, da Silva Franco JF, López-Valdez J, et al. Corrigendum to "The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII" [Mol Genet Metab 2020 Mar;129(3):219-227]. Mol Genet Metab. 2020;131(1):285doi: 10.1016/j.ymgme.2020.08.001.
Wang, R. Y., da Silva Franco, J. F., López-Valdez, J., Martins, E., Sutton, V. R., Whitley, C. B., Zhang, L., Cimms, T., Marsden, D., Jurecka, A., & Harmatz, P. (2020). Corrigendum to "The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII" [Mol Genet Metab 2020 Mar;129(3):219-227]. Molecular genetics and metabolism, 131(1), 285. https://doi.org/10.1016/j.ymgme.2020.08.001
Wang, Raymond Y, et al. "Corrigendum to "The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII" [Mol Genet Metab 2020 Mar;129(3):219-227]." Molecular genetics and metabolism vol. 131,1 (2020): 285. doi: https://doi.org/10.1016/j.ymgme.2020.08.001
Wang RY, da Silva Franco JF, López-Valdez J, Martins E, Sutton VR, Whitley CB, Zhang L, Cimms T, Marsden D, Jurecka A, Harmatz P. Corrigendum to "The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII" [Mol Genet Metab 2020 Mar;129(3):219-227]. Mol Genet Metab. 2020 Sep - Oct;131(1):285. doi: 10.1016/j.ymgme.2020.08.001. Epub 2020 Aug 23. PMID: 32843286.
Copy Download .nbib Format: NLM
Ecological Drawbacks of Nanomaterials Produced on an Industrial Scale: Collateral Effect on Human and Environmental Health.

Water, air, and soil pollution

Pérez-Hernández H, Pérez-Moreno A, Sarabia-Castillo CR, García-Mayagoitia S, Medina-Pérez G, López-Valdez F, Campos-Montiel RG, Jayanta-Kumar P, Fernández-Luqueño F.
PMID: 34658457
Water Air Soil Pollut. 2021;232(10):435. doi: 10.1007/s11270-021-05370-2. Epub 2021 Oct 12.

Currently, hundreds of different nanomaterials with a broad application in products that make daily lives a little bit easier, in every aspect, are being produced on an industrial scale at thousands of tons per year. However, several scientists, researchers,...

Cite
Pérez-Hernández H, Pérez-Moreno A, Sarabia-Castillo CR, et al. Ecological Drawbacks of Nanomaterials Produced on an Industrial Scale: Collateral Effect on Human and Environmental Health. Water Air Soil Pollut. 2021;232(10):435doi: 10.1007/s11270-021-05370-2.
Pérez-Hernández, H., Pérez-Moreno, A., Sarabia-Castillo, C. R., García-Mayagoitia, S., Medina-Pérez, G., López-Valdez, F., Campos-Montiel, R. G., Jayanta-Kumar, P., & Fernández-Luqueño, F. (2021). Ecological Drawbacks of Nanomaterials Produced on an Industrial Scale: Collateral Effect on Human and Environmental Health. Water, air, and soil pollution, 232(10), 435. https://doi.org/10.1007/s11270-021-05370-2
Pérez-Hernández, H, et al. "Ecological Drawbacks of Nanomaterials Produced on an Industrial Scale: Collateral Effect on Human and Environmental Health." Water, air, and soil pollution vol. 232,10 (2021): 435. doi: https://doi.org/10.1007/s11270-021-05370-2
Pérez-Hernández H, Pérez-Moreno A, Sarabia-Castillo CR, García-Mayagoitia S, Medina-Pérez G, López-Valdez F, Campos-Montiel RG, Jayanta-Kumar P, Fernández-Luqueño F. Ecological Drawbacks of Nanomaterials Produced on an Industrial Scale: Collateral Effect on Human and Environmental Health. Water Air Soil Pollut. 2021;232(10):435. doi: 10.1007/s11270-021-05370-2. Epub 2021 Oct 12. PMID: 34658457; PMCID: PMC8507508.
Copy Download .nbib Format: NLM
Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury.

Theranostics

Amo-Aparicio J, Garcia-Garcia J, Francos-Quijorna I, Urpi A, Esteve-Codina A, Gut M, Quintana A, Lopez-Vales R.
PMID: 34815787
Theranostics. 2021 Oct 03;11(20):9805-9820. doi: 10.7150/thno.65203. eCollection 2021.

No abstract available.

Cite
Amo-Aparicio J, Garcia-Garcia J, Francos-Quijorna I, et al. Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury. Theranostics. 2021;11(20):9805-9820doi: 10.7150/thno.65203.
Amo-Aparicio, J., Garcia-Garcia, J., Francos-Quijorna, I., Urpi, A., Esteve-Codina, A., Gut, M., Quintana, A., & Lopez-Vales, R. (2021). Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury. Theranostics, 11(20), 9805-9820. https://doi.org/10.7150/thno.65203
Amo-Aparicio, Jesus, et al. "Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury." Theranostics vol. 11,20 (2021): 9805-9820. doi: https://doi.org/10.7150/thno.65203
Amo-Aparicio J, Garcia-Garcia J, Francos-Quijorna I, Urpi A, Esteve-Codina A, Gut M, Quintana A, Lopez-Vales R. Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury. Theranostics. 2021 Oct 03;11(20):9805-9820. doi: 10.7150/thno.65203. eCollection 2021. PMID: 34815787; PMCID: PMC8581417.
Copy Download .nbib Format: NLM
Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury.

Experimental neurology

Amo-Aparicio J, Garcia-Garcia J, Puigdomenech M, Francos-Quijorna I, Skouras DB, Dinarello CA, Lopez-Vales R.
PMID: 34624330
Exp Neurol. 2022 Jan;347:113889. doi: 10.1016/j.expneurol.2021.113889. Epub 2021 Oct 12.

Spinal cord injury (SCI) leads to irreversible functional deficits due to the disruption of axons and the death of neurons and glial cells. The inflammatory response that occurs in the injured spinal cord results in tissue degeneration; thus, targeting...

Cite
Amo-Aparicio J, Garcia-Garcia J, Puigdomenech M, et al. Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury. Exp Neurol. 2021;347:113889doi: 10.1016/j.expneurol.2021.113889.
Amo-Aparicio, J., Garcia-Garcia, J., Puigdomenech, M., Francos-Quijorna, I., Skouras, D. B., Dinarello, C. A., & Lopez-Vales, R. (2022). Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury. Experimental neurology, 347113889. https://doi.org/10.1016/j.expneurol.2021.113889
Amo-Aparicio, Jesus, et al. "Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury." Experimental neurology vol. 347 (2022): 113889. doi: https://doi.org/10.1016/j.expneurol.2021.113889
Amo-Aparicio J, Garcia-Garcia J, Puigdomenech M, Francos-Quijorna I, Skouras DB, Dinarello CA, Lopez-Vales R. Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury. Exp Neurol. 2022 Jan;347:113889. doi: 10.1016/j.expneurol.2021.113889. Epub 2021 Oct 12. PMID: 34624330.
Copy Download .nbib Format: NLM
Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury.

Theranostics

Amo-Aparicio J, Garcia-Garcia J, Francos-Quijorna I, Urpi A, Esteve-Codina A, Gut M, Quintana A, Lopez-Vales R.
PMID: 34815787
Theranostics. 2021 Oct 03;11(20):9805-9820. doi: 10.7150/thno.65203. eCollection 2021.

No abstract available.

Cite
Amo-Aparicio J, Garcia-Garcia J, Francos-Quijorna I, et al. Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury. Theranostics. 2021;11(20):9805-9820doi: 10.7150/thno.65203.
Amo-Aparicio, J., Garcia-Garcia, J., Francos-Quijorna, I., Urpi, A., Esteve-Codina, A., Gut, M., Quintana, A., & Lopez-Vales, R. (2021). Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury. Theranostics, 11(20), 9805-9820. https://doi.org/10.7150/thno.65203
Amo-Aparicio, Jesus, et al. "Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury." Theranostics vol. 11,20 (2021): 9805-9820. doi: https://doi.org/10.7150/thno.65203
Amo-Aparicio J, Garcia-Garcia J, Francos-Quijorna I, Urpi A, Esteve-Codina A, Gut M, Quintana A, Lopez-Vales R. Interleukin-4 and interleukin-13 induce different metabolic profiles in microglia and macrophages that relate with divergent outcomes after spinal cord injury. Theranostics. 2021 Oct 03;11(20):9805-9820. doi: 10.7150/thno.65203. eCollection 2021. PMID: 34815787; PMCID: PMC8581417.
Copy Download .nbib Format: NLM
Evaluation of the genotoxicity, cytotoxicity and antimalarial effect of sodium metavanadate .

Toxicology reports

Casarrubias-Tabarez B, Rivera-Fernández N, Rojas-Lemus M, López-Valdez N, Fortoul TI.
PMID: 32874923
Toxicol Rep. 2020 Aug 15;7:1001-1007. doi: 10.1016/j.toxrep.2020.08.006. eCollection 2020.

Malaria is a parasitic disease with the highest morbidity and mortality worldwide and antimalarial drug resistance has increased in last two decades. Chloroquine and artemisinin which were usedfor the treatment of malaria are also reported with resistances. Recently, some...

Cite
Casarrubias-Tabarez B, Rivera-Fernández N, Rojas-Lemus M, et al. Evaluation of the genotoxicity, cytotoxicity and antimalarial effect of sodium metavanadate . Toxicol Rep. 2020;7:1001-1007doi: 10.1016/j.toxrep.2020.08.006.
Casarrubias-Tabarez, B., Rivera-Fernández, N., Rojas-Lemus, M., López-Valdez, N., & Fortoul, T. I. (2020). Evaluation of the genotoxicity, cytotoxicity and antimalarial effect of sodium metavanadate . Toxicology reports, 71001-1007. https://doi.org/10.1016/j.toxrep.2020.08.006
Casarrubias-Tabarez, Brenda, et al. "Evaluation of the genotoxicity, cytotoxicity and antimalarial effect of sodium metavanadate ." Toxicology reports vol. 7 (2020): 1001-1007. doi: https://doi.org/10.1016/j.toxrep.2020.08.006
Casarrubias-Tabarez B, Rivera-Fernández N, Rojas-Lemus M, López-Valdez N, Fortoul TI. Evaluation of the genotoxicity, cytotoxicity and antimalarial effect of sodium metavanadate . Toxicol Rep. 2020 Aug 15;7:1001-1007. doi: 10.1016/j.toxrep.2020.08.006. eCollection 2020. PMID: 32874923; PMCID: PMC7451625.
Copy Download .nbib Format: NLM
ATP6V0A2 mutations present in two Mexican Mestizo children with an autosomal recessive cutis laxa syndrome type IIA.

Molecular genetics and metabolism reports

Bahena-Bahena D, López-Valdez J, Raymond K, Salinas-Marín R, Ortega-García A, Ng BG, Freeze HH, Ruíz-García M, Martínez-Duncker I.
PMID: 27896089
Mol Genet Metab Rep. 2014 Apr 25;1:203-212. doi: 10.1016/j.ymgmr.2014.04.003. eCollection 2014.

Patients with ARCL-IIA harbor mutations in ATP6V0A2 that codes for an organelle proton pump. The ARCL-IIA syndrome characteristically presents a combined glycosylation defect affecting

Cite
Bahena-Bahena D, López-Valdez J, Raymond K, et al. ATP6V0A2 mutations present in two Mexican Mestizo children with an autosomal recessive cutis laxa syndrome type IIA. Mol Genet Metab Rep. 2014;1:203-212doi: 10.1016/j.ymgmr.2014.04.003.
Bahena-Bahena, D., López-Valdez, J., Raymond, K., Salinas-Marín, R., Ortega-García, A., Ng, B. G., Freeze, H. H., Ruíz-García, M., & Martínez-Duncker, I. (2014). ATP6V0A2 mutations present in two Mexican Mestizo children with an autosomal recessive cutis laxa syndrome type IIA. Molecular genetics and metabolism reports, 1203-212. https://doi.org/10.1016/j.ymgmr.2014.04.003
Bahena-Bahena, D, et al. "ATP6V0A2 mutations present in two Mexican Mestizo children with an autosomal recessive cutis laxa syndrome type IIA." Molecular genetics and metabolism reports vol. 1 (2014): 203-212. doi: https://doi.org/10.1016/j.ymgmr.2014.04.003
Bahena-Bahena D, López-Valdez J, Raymond K, Salinas-Marín R, Ortega-García A, Ng BG, Freeze HH, Ruíz-García M, Martínez-Duncker I. ATP6V0A2 mutations present in two Mexican Mestizo children with an autosomal recessive cutis laxa syndrome type IIA. Mol Genet Metab Rep. 2014 Apr 25;1:203-212. doi: 10.1016/j.ymgmr.2014.04.003. eCollection 2014. PMID: 27896089; PMCID: PMC5121299.
Copy Download .nbib Format: NLM
Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury.

Experimental neurology

Amo-Aparicio J, Garcia-Garcia J, Puigdomenech M, Francos-Quijorna I, Skouras DB, Dinarello CA, Lopez-Vales R.
PMID: 34624330
Exp Neurol. 2022 Jan;347:113889. doi: 10.1016/j.expneurol.2021.113889. Epub 2021 Oct 12.

Spinal cord injury (SCI) leads to irreversible functional deficits due to the disruption of axons and the death of neurons and glial cells. The inflammatory response that occurs in the injured spinal cord results in tissue degeneration; thus, targeting...

Cite
Amo-Aparicio J, Garcia-Garcia J, Puigdomenech M, et al. Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury. Exp Neurol. 2021;347:113889doi: 10.1016/j.expneurol.2021.113889.
Amo-Aparicio, J., Garcia-Garcia, J., Puigdomenech, M., Francos-Quijorna, I., Skouras, D. B., Dinarello, C. A., & Lopez-Vales, R. (2022). Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury. Experimental neurology, 347113889. https://doi.org/10.1016/j.expneurol.2021.113889
Amo-Aparicio, Jesus, et al. "Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury." Experimental neurology vol. 347 (2022): 113889. doi: https://doi.org/10.1016/j.expneurol.2021.113889
Amo-Aparicio J, Garcia-Garcia J, Puigdomenech M, Francos-Quijorna I, Skouras DB, Dinarello CA, Lopez-Vales R. Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury. Exp Neurol. 2022 Jan;347:113889. doi: 10.1016/j.expneurol.2021.113889. Epub 2021 Oct 12. PMID: 34624330.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries